Bioepuivalence Study for the Safety and the Pharmacokinetics of DWJ1589 and DWC202315

Trial statusNot yet recruiting

Trial phasePhase 1

Trial typeInterventional

Biological sexAll

Age19+

SponsorDaewoong Pharmaceutical Co. LTD.

About this trial

This study aims to evaluate the safety and pharmacokinetic characteristics after administration of DWJ1589 and DWC202315 in healty adult volunteers.

Over 19 year old

Healthy adult volunteers

with a history of mental disorder

For female volunteers, those who are suspected of being pregnant or lactating

52 Participants

are divided into 2 treatment groups

This trial has no locations

Daewoong Pharmaceutical Co. LTD.

Lead sponsor